This article is more than 5 years old. Information may no longer be current.

Ranbaxy issues voluntary recall of OTC loratadine slow-release

Ranbaxy Laboratories has issued a voluntary recall of approximately 30,000 blister packs of over-the-counter, loratadine slow-release tablets due to blister defects, according to a weekly FDA enforcement report.

The recall includes Non-Drowsy 24-Hour Formula Allergy Relief and Nasal Decongestant, Pseudoephedrine Sulfate, USP 240 mg, Loratadine, USP, 10 mg, five-, 10-, 15-count blister packs sold at CVS, Discount Drug Mart, Kroger, Sunmark, Good Neighbor Pharmacy, H-E-B, and Rite-Aid in California, Ohio, Pennsylvania, Rhode Island and Texas, with an expiration date of September 2015, according to the report.

The Class 2 recall indicates that the product, which originated at Ohm Laboratories in New Jersey is defective, including “an unacceptable level of blister defects,” the report said.

The lot numbers in the recall are: 2554936 and 2554938.

For more information:

FDA Enforcement Report: Week of April 30, 2014. Accessed May 6, 2014.